Live
POLYMED logoPOLYMEDstock

Poly Medicure Ltd

₹1,535.55
+1.32%
Open
₹1,509.7
High
₹1,555.35
Low
₹1,509.7
Volume
78.3K

Price chart

Daily close · downsampled 5-year history

2021-06-21 · ₹909.352026-06-18 · ₹1,555.45

Instrument details

MB Code
MBEQU3559
Type
stock
ISIN
INE205C01021
BSE
531768

Latest earnings

Q4FY26 declared

Quarter
Mar 2026
Revenue
534.51 Cr
Net profit
65.04 Cr
EPS
6.53
YoY revenue
+21.25%

Price returns

Historical performance

1 day
+1.13%
1 month
+6.89%
3 months
+25.28%
1 year
-27.19%
3 years
+35.79%
5 years
+72.32%

Technicals

Indicator consensus

Bullish
34
Neutral
3
Bearish
9
RSI 76.53(Bearish)

Corporate timeline

Price chart events · 1 year

Dividend
2025-09-18
{"amount":3.5}
Earnings
2026-02-05
{"actualRevenue":4936555000,"estimateRevenue":5098000000,"revenueSurprise":-161445000,"revenueSurprisePercent":-3.166830129462534,"actualEPS":7.66,"estimateEPS":9.741000000000001,"surprise":-2.081000000000001,"surprisePercent":-21.36330972179449}
Earnings
2026-05-25
{"actualRevenue":5345114000,"estimateRevenue":5542000000,"revenueSurprise":-196886000,"revenueSurprisePercent":-3.552616383976904,"actualEPS":6.53,"estimateEPS":7.956,"surprise":-1.425999999999999,"surprisePercent":-17.92357968828556}
News
2025-09-24
{"description":"Poly Medicure Ltd is acquiring Italy's Citieffe Group for ₹324 crore to expand its orthopaedics market presence. The deal, expected to close in 4-8 weeks, aims to enhance its product portfolio in trauma and extremities. Shares rose by 1.64% post-announcement.","url":"https://www.cnbctv18.com/market/stocks/poly-medicure-share-price-to-acquire-italys-citieffe-group-for-rs-324-crore-in-orthopaedics-expansion-19687292.htm","sentiment":"Positive","domain":"CNBCTV18"}
News
2025-09-24
{"description":"Poly Medicure Ltd is acquiring Italy's Citieffe Group for Rs 324 crore to boost its global orthopaedics market presence, focusing on trauma and extremities. The deal, expected to close in 4-8 weeks, supports Poly Medicure's aim to be a comprehensive healthcare provider.","url":"https://money.rediff.com/news/market/poly-medicure-acquires-citieffe-group-for-rs-324-cr/34211720250924","sentiment":"Positive","domain":"Rediff Money"}
News
2025-09-04
{"description":"Poly Medicure Ltd will acquire a 90% stake in Netherlands-based Pendracare Group for ₹188.5 crore, enhancing its portfolio in the medical device sector.","url":"https://www.business-standard.com/markets/news/poly-medicure-to-buy-90-stake-in-pendracare-group-for-188-5-crore-125090301285_1.html","sentiment":"Positive","domain":"Business Standard"}
News
2025-09-03
{"description":"Poly Medicure is set to acquire a 90% stake in Netherlands-based PendraCare Group for ₹188.5 crore, with the remaining 10% to be acquired in 2030 based on Ebitda performance.","url":"https://www.msn.com/en-in/money/general/poly-medicure-to-acquire-majority-stake-in-pendracare-group-for-188-5-crore/ar-AA1LNIHH?ocid=BingNewsVerp","sentiment":"Positive","domain":"Business Today on MSN"}
News
2025-09-03
{"description":"Poly Medicure will acquire 90% of Netherlands-based PendraCare Group for ₹188.5 crore.","url":"https://www.business-standard.com/industry/news/poly-medicure-to-acquire-netherlands-pendracare-group-for-rs-188-crore-125090301349_1.html","sentiment":"Positive","domain":"Business Standard"}
News
2025-09-03
{"description":"Polymed plans to acquire 90% of Netherlands-based PendraCare for ₹189 crore to enhance its cardiology business, focusing on innovative catheter solutions and design services.","url":"https://www.cnbctv18.com/market/stocks/poly-medicure-share-price-to-acquire-90-pc-stake-in-netherlands-based-pendracare-for-rs-189-crore-cardiology-business-19664088.htm","sentiment":"Positive","domain":"CNBCTV18"}
News
2025-08-11
{"description":"Poly Medicure plans to invest ₹500 crore in three new plants focused on renal, cardiology, and oncology products, aiming to expand its presence in the US, Brazil, and other global markets.","url":"https://www.business-standard.com/companies/news/poly-medicure-us-europe-expansion-new-manufacturing-facilities-125081101559_1.html","sentiment":"Positive","domain":"Business Standard"}